Frequently Asked Questions

Signs may include:^1.

• Tremors, or involuntary shaking, in hands, arms, legs, head or jaw
• Stiffness or contracting of the muscles that may cause pain or limit your range of motion
• Slowed movement, called bradykinesia, when walking, getting up out of a chair, etc.
• Impaired balance and coordination, sometimes leading to falls
• Stooped or slumped posture
• Difficulty with speech, handwriting, or with unconscious movements like blinking, smiling, swinging of the arms when walking

1. Source: https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055

You should consider applying for a clinical study if you or a loved one:

• Are between the ages of 41-80 years old
• Have a clinically-confirmed diagnosis of Parkinson’s disease, and experience motor symptoms
• Are not currently taking levodopa and are willing to delay starting its use

Most clinical trials will involve frontline screening to confirm that a potential patient is, in fact, a match for that study’s criteria. Once verified and the patient has signed an Informed Consent Form, which clearly provides the details and purpose of the study to that individual and what it involves, participants may expect to attend scheduled appointments at a clinician’s office. They will also receive an investigational medication or placebo and undergo additional screening and regular follow-up monitoring.

The information gleaned from clinical studies may help identify new treatment options in the future for people living with PD. Study participants are often connected to specialists who understand their situation and can help answer questions from patients or their loved ones.

In almost all instances, there is no cost to participate in a clinical trial. Participants receive all study-related medical care and medications for the duration of the study at no cost. Likewise in many instances, patients also enjoy benefits such as reimbursement for study-related time and travel.

As all drugs and medical procedures carry a risk of side effects, the possibility that participants may experience some discomfort or other reactions during or after a clinical trial does exist. The study staff for that trial should explain these potential risks before participants decide whether to enroll, and help address any concerns.

No. Requirements or eligibility criteria vary by clinical trial, and sponsors/clinical sites are constantly looking for patient populations in order to test the efficacy and safety of their investigational drugs. Further screening will determine whether a patient is eligible to participate in an active clinical study, but if not, they will likely be a candidate for one in the future, in which case that person may expect to be contacted. At that point, and before a potential participant decides whether to take part in the study, the study staff will review the informed consent form with them and answer any questions. Once the consent form has been signed by the participant, the screening period of the study begins.

Yes. Participation in clinical trials is entirely voluntary. Even if a participant is already involved in a study, they may change their mind at any time, for any reason.

If you are interested in learning more, please contact us at any time. You may email us at help@clinicalenrollment.com.